The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So the other option is basically oncologists learning more about the metabolism of cancer so that when it comes to managing understood and predictable complications of these medications, which are actually desired features, as you point out, if you're using this drug correctly, you should see hyperinsulinemia and hyperglycemia and you should treat it accordingly.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.